Carregant...
The Hepatitis B Virus Ribonuclease H as a Drug Target
Chronic hepatitis B virus (HBV) infection is a leading cause of hepatitis, liver failure, and hepatocellular carcinoma. An outstanding vaccine is available; however the number of infections remains high. Current anti-HBV treatments with interferon α and nucleos(t)ide analogs clear the infection in o...
Guardat en:
| Publicat a: | Antiviral Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4424167/ https://ncbi.nlm.nih.gov/pubmed/25862291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.04.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|